Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00548392
What this trial is testing

Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement

Who this might be right for
Breast Cancer
Fred Hutchinson Cancer Center 25
Not applicableLooking for participantsNCT05906407
What this trial is testing

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

Who this might be right for
Early-Stage Breast CancerNeoadjuvant Therapy
German Cancer Research Center 2,000
Not applicableStudy completedNCT06851221
What this trial is testing

Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma

Who this might be right for
NeuroblastomaEwing Sarcoma
Meyer Children's Hospital IRCCS 95
Not applicableStudy completedNCT01380899
What this trial is testing

Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Universidad Autonoma de San Luis Potosí 87
Not applicableStudy completedNCT00571025
What this trial is testing

Risk Evaluation and Education for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
National Human Genome Research Institute (NHGRI) 301
Not applicableStudy completedNCT00521976
What this trial is testing

Risk Markers in the Acute Coronary Syndromes

Who this might be right for
Chest PainCoronary Artery DiseaseUnstable Angina Pectoris+1 more
Helse Stavanger HF 871
Not applicableUnknownNCT05279638
What this trial is testing

ATG5 as a Serum Marker of Autophagy in Psoriatic Patient

Who this might be right for
Psoriasis VulgarisAutophagy
Sohag University 90
Not applicableLooking for participantsNCT03268668
What this trial is testing

Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis

Who this might be right for
Stroke, AcuteBiological Specimen BanksBiomarkers+2 more
Fondation Ophtalmologique Adolphe de Rothschild 1,200
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Not applicableStudy completedNCT04139408
What this trial is testing

Safety and Effectiveness of Disposable Pulmonary Surgical Markers in the Localization of Pulmonary Nodules

Who this might be right for
Lung Cancer
Hangzhou Broncus Medical Co., Ltd. 76
Very early researchStudy completedNCT01576159
What this trial is testing

Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises

Who this might be right for
OsteoarthritisArticular Cartilage Disorder of KneeDegenerative Lesion of Articular Cartilage of Knee
Middle East Technical University 48
Not applicableUnknownNCT04328194
What this trial is testing

Autotaxin (ATX) as a Marker for Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 100
Not applicableStudy completedNCT06143761
What this trial is testing

Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer

Who this might be right for
Oral Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 206
Not applicableStudy completedNCT01358461
What this trial is testing

Validation of a Non Invasive Blood Marker of SIDS and Vagal Disorders

Who this might be right for
Vagal Syncope
University Hospital, Strasbourg, France 240
Testing effectiveness (Phase 2)Looking for participantsNCT05704829
What this trial is testing

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Women's Cancer Study Group GmbH 702
Very early researchStudy completedNCT01436188
What this trial is testing

Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
HealthyAlzheimer Disease
Janssen Research & Development, LLC 5
Not applicableUnknownNCT05161988
What this trial is testing

Serum IL 26 as a Marker of Disease Activity in SLE

Who this might be right for
SLE
Assiut University 52
Testing effectiveness (Phase 2)UnknownNCT05820191
What this trial is testing

B-amyloid as a Marker for GBM Bioimaging

Who this might be right for
Glioblastoma
Universidad Central del Caribe 3
Not applicableStudy completedNCT04779983
What this trial is testing

IL-6 as a Biomarker for Personalized Treatment of PR

Who this might be right for
Rheumatoid Arthritis
University Hospital, Montpellier 200
Not applicableStudy completedNCT06216483
What this trial is testing

Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium

Who this might be right for
Delirium in Old Age
Indiana University 60
Next Page